$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000101473920000020 Filed on May 07, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$705.4M	$476.5M
YoY Change	48.05%	182.64%
Cost Of Revenue	$547.4M	$121.3M
YoY Change	351.32%	6.83%
Gross Profit	$158.0M	$98.19M
YoY Change	60.94%	-3.44%
Gross Profit Margin	22.4%	20.61%
Selling, General & Admin	$129.3M	$82.79M
YoY Change	56.16%	673.71%
% of Gross Profit	81.81%	84.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.10M	$9.969M
YoY Change	101.64%	53.7%
% of Gross Profit	12.72%	10.15%
Operating Expenses	$149.4M	$92.76M
YoY Change	61.05%	59.0%
Operating Profit	$8.648M	$5.438M
YoY Change	59.03%	77.42%
Interest Expense	$28.09M	$11.05M
YoY Change	154.3%	-182.46%
% of Operating Profit	324.78%	203.11%
Other Income/Expense, Net	$8.000K	-$5.156M
YoY Change	-100.16%	-46.58%
Pretax Income	-$18.90M	-$10.27M
YoY Change	84.1%	-20.66%
Income Tax	$1.000M	-$1.400M
% Of Pretax Income
Net Earnings	-$19.91M	-$3.712M
YoY Change	436.37%	-45.82%
Net Earnings / Revenue	-2.82%	-0.78%
Basic Earnings Per Share	-$0.11	-$0.03
Diluted Earnings Per Share	-$0.11	-$0.03
COMMON SHARES
Basic Shares Outstanding	176.7M shares	128.1M shares
Diluted Shares Outstanding		131.4M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$77.20M	$5.700M
YoY Change	1254.39%	-81.25%
Cash & Equivalents	$77.24M	$5.703M
Short-Term Investments
Other Short-Term Assets	$47.70M	$17.10M
YoY Change	178.95%	8.23%
Inventory	$139.1M	$27.47M
Prepaid Expenses
Receivables	$337.2M	$120.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$601.3M	$171.1M
YoY Change	251.45%	-2.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$125.8M	$27.80M
YoY Change	352.5%	11.32%
Goodwill	$1.428B	$632.5M
YoY Change	125.76%	72.24%
Intangibles
YoY Change
Long-Term Investments	$17.00M
YoY Change
Other Assets	$21.73M	$1.719M
YoY Change	1163.82%	-17.44%
Total Long-Term Assets	$2.011B	$426.1M
YoY Change	372.01%	3.69%
TOTAL ASSETS
Total Short-Term Assets	$601.3M	$171.1M
Total Long-Term Assets	$2.011B	$426.1M
Total Assets	$2.613B	$597.2M
YoY Change	337.47%	1.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$265.7M	$77.46M
YoY Change	243.03%	12.53%
Accrued Expenses	$100.9M	$32.70M
YoY Change	208.56%	8.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.250M	$4.500M
YoY Change	105.56%	309.09%
Total Short-Term Liabilities	$379.0M	$115.6M
YoY Change	227.91%	11.47%
LONG-TERM LIABILITIES
Long-Term Debt	$1.276B	$506.7M
YoY Change	151.89%	5.47%
Other Long-Term Liabilities	$29.70M	$15.75M
YoY Change	88.64%	-13.88%
Total Long-Term Liabilities	$1.363B	$15.75M
YoY Change	8556.81%	-13.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$379.0M	$115.6M
Total Long-Term Liabilities	$1.363B	$15.75M
Total Liabilities	$1.742B	$657.3M
YoY Change	165.04%	9.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$111.9M	-$771.5M
YoY Change	-85.5%	6.78%
Common Stock	$1.009B	$616.5M
YoY Change	63.6%	-0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.403M	$1.336M
YoY Change	79.87%	277.4%
Treasury Stock Shares	383.7K shares	407.2K shares
Shareholders Equity	$870.5M	$597.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.613B	$597.2M
YoY Change	337.47%	1.76%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$19.91M	-$3.712M
YoY Change	436.37%	-45.82%
Depreciation, Depletion And Amortization	$20.10M	$9.969M
YoY Change	101.64%	53.7%
Cash From Operating Activities	$18.40M	$9.080M
YoY Change	102.68%	-274.88%
INVESTING ACTIVITIES
Capital Expenditures	$5.353M	$5.367M
YoY Change	-0.26%	102.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$636.0K
YoY Change	-100.0%
Cash From Investing Activities	-$5.353M	-$4.731M
YoY Change	13.15%	78.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.862M	-$3.038M
YoY Change	-5.79%	139.78%
NET CHANGE
Cash From Operating Activities	$18.40M	$9.080M
Cash From Investing Activities	-$5.353M	-$4.731M
Cash From Financing Activities	-$2.862M	-$3.038M
Net Change In Cash	$10.19M	$1.311M
YoY Change	677.12%	-114.4%
FREE CASH FLOW
Cash From Operating Activities	$18.40M	$9.080M
Capital Expenditures	$5.353M	$5.367M
Free Cash Flow	$13.05M	$3.713M
YoY Change	251.47%	-147.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	81245000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7195000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1008570000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	584000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	757000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	799000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1396000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8800000	USD
CY2019Q4	us-gaap	Assets Assets	2589547000	USD
CY2019Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	33538000	USD
CY2020Q1	us-gaap	Assets Assets	2612531000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	558654000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	601272000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2030893000	USD
CY2020Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2011259000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67056000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77244000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36391000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37702000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67056000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77244000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1311000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10188000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	176975628	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	177088028	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	176591907	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	176704306	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2020Q1	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	32302000	USD
CY2019Q1	bios	Adjustments To Additional Paid In Capital Stockholders Redemption AdjustmentsToAdditionalPaidInCapitalStockholdersRedemption	2000000	USD
CY2019Q1	bios	Interest On Management Notes Receivable InterestOnManagementNotesReceivable	21000	USD
CY2020Q1	bios	Number Of Equity Method Investments NumberOfEquityMethodInvestments	2	investment
CY2019Q1	bios	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	4231000	USD
CY2020Q1	bios	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	4764000	USD
CY2020Q1	bios	Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings	549000	USD
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	176712333	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	Option Care Health, Inc.
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	221060000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	265703000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	324416000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337197000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78622000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23827000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1008362000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4217000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36542000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	378298000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	547411000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1337256000	USD
CY2020Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1334944000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	20071000	USD
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19575000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	30689000	USD
CY2020Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	29790000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2082000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	300000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2143000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2443000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	5853000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	13061000	USD
CY2019Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	10749000	USD
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	21844000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9969000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20101000	USD
CY2019Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-183000	USD
CY2020Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1033000	USD
CY2019Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	7285000	USD
CY2020Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	24142000	USD
CY2019Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.277
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.055
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45765000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	52416000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	17000000	USD
CY2020Q1	us-gaap	Equity Method Investments EquityMethodInvestments	17000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	97149000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	105863000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	483059000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	483059000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	385910000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	377196000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1425542000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	1427883000	USD
CY2020Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2341000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	98194000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	158029000	USD
CY2019Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5134000	USD
CY2020Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-18869000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	549000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	562000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	600000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1422000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1041000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	180000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	307000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3395000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	42302000	USD
CY2019Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1139000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	6651000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6690000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23252000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7217000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1650000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	162000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-563000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7263000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3603000	USD
CY2019Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-266000	USD
CY2020Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	12781000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	11045000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	28087000	USD
CY2019Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-10572000	USD
CY2020Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27517000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	6321000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	25936000	USD
CY2020Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	18000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	115876000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	139128000	USD
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	549000	USD
CY2020Q1	us-gaap	Investment Income Net InvestmentIncomeNet	562000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88608000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	18327000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8008000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10767000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14103000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19201000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	18202000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14715000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1682720000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	1742038000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2589547000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2612531000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	330004000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	379023000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1352716000	USD
CY2020Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1363015000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	1286496000	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	1285579000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1291006000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9250000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	6938000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1277246000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1276329000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3038000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2862000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4731000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5353000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9080000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18403000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-3712000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-19910000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	92756000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	149381000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	5438000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8648000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	5200000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7700000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	73893000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20391000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19352000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58242000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54541000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3765000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4740000	USD
CY2019Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	4671000	USD
CY2020Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	6798000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63502000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58669000	USD
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0547
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	700000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22741000	USD
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M19D
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111865000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21725000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-505000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-16632000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-242000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-747000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-16632000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-505000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16632000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15085000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29702000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-76000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-535000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-882000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-636000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	549000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5367000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5353000	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	12500000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	12500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	51306000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	47703000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	211820000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	207031000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	133198000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	125786000	USD
CY2019Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	1038000	USD
CY2020Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2313000	USD
CY2019Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2000000	USD
CY2020Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-91955000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476492000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	705440000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	82787000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129280000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	584000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	757000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	602825000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	597171000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	906827000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	870493000	USD
CY2020Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	383722	shares
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	383722	shares
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2403000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2403000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	142614000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	176661000	shares

Files In Submission

Name	View Source	Status
0001014739-20-000020-index-headers.html	Edgar Link	pending
0001014739-20-000020-index.html	Edgar Link	pending
0001014739-20-000020.txt	Edgar Link	pending
0001014739-20-000020-xbrl.zip	Edgar Link	pending
bios-20200331.xml	Edgar Link	completed
bios-20200331.xsd	Edgar Link	pending
bios-20200331_cal.xml	Edgar Link	unprocessable
bios-20200331_def.xml	Edgar Link	unprocessable
bios-20200331_lab.xml	Edgar Link	unprocessable
bios-20200331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
opch-20200331x10q.htm	Edgar Link	pending
opch-ex311x20200331x10q.htm	Edgar Link	pending
opch-ex312x20200331x10q.htm	Edgar Link	pending
opch-ex321x20200331x10q.htm	Edgar Link	pending
opch-ex322x20200331x10q.htm	Edgar Link	pending
optioncarehealthrgba08.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2020 Q1 Form 10-Q Financial Statement

#000101473920000020 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2020 Q1 Form 10-Q Financial Statement

#000101473920000020 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch